Clinical Drug Experience Knowledgebase

Brain Diseases (Phase 2)

Carbon Monoxide Poisoning (Phase 2)

Colitis (Phase 2)

Colitis, Ulcerative (Phase 2)

Disease Susceptibility (Phase 4)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis B (Phase 4)

Hepatitis B, Chronic (Phase 4)

Hepatitis, Chronic (Phase 4)

Hypersensitivity (Phase 4)

Hypertension (Phase 2)

Hypertension, Pulmonary (Phase 2)

Intracranial Arteriosclerosis (Phase 2)

Intracranial Embolism (Phase 2)

Intracranial Thrombosis (Phase 2)

Leprosy (Phase 4)

Osteoarthritis (Phase 2)

Osteoarthritis, Knee (Phase 2)

Pneumonia, Pneumocystis (Phase 4)

Poisoning (Phase 2)

Purpura, Thrombocytopenic, Idiopathic (Phase 3)

Skin Diseases (Phase 4)

Skin Diseases, Vesiculobullous (Phase 4)

Thrombocytopenia (Phase 3)

Ulcer (Phase 2)

Urticaria (Phase 4)

Vasculitis (Phase 4)

Vasculitis, Leukocytoclastic, Cutaneous (Phase 4)